Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient, and clinically relevant delivery modalities 1,2. Here we demonstrate the safety and efficiency of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback